Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

RESULTS OF THE EXTRAORDINARY GENERAL MEETING

4 Sep 2020 09:42

RNS Number : 0114Y
MD Medical Group Investments PLC
03 September 2020
 

 

RESULTS OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 

04 September 2020, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, today announces that the Company held its Extraordinary General Meeting of shareholders ("GM"). The GM was held at Lapino hospital, 111, Lapino Village, Odintsovskiy district, Moscow Region, Russian Federation on September 03, 2020 at 10.00 а.m. local time, and had a 100% quorum with 75,125,010 shares present.

The GM passed the following resolution unanimously:

"THAT the payment of a dividend out of the profit of the Company according to the audited separate financial statements prepared for 2019 in the amount of RUR 1 389 812 685 including:

∙ RUR 1 035 820 201,49 - the net income received for 2019,

∙ RUR 107 300 601,05 - the part of the undistributed profit for 2018,

∙ RUR 246 691 882,46 - the part of the undistributed profit for 2017

or in the amount of RUR 18,50 per share, as proposed in the directors' report be and is hereby approved. Subject to shareholders' approval of the dividend at the extraordinary general meeting of shareholders of the Company, the dividend record date is set as September 16, 2020. The Global Depository Receipts will be marked as ex-dividend on September 15, 2020. The pay date for GDR holders is set as October 13, 2020. The payment shall be made in USD at the rate of the Central Bank of Russia on the 11 August 2020."

The minutes of the GM will be available for viewing at the registered office of the Company at office 9-2, bld. 3, 6 Azovskaya str., Moscow, Russian Federation and will be available at the National Storage Mechanism of the UK Listing Authority, located at https://data.fca.org.uk/, in due course.

 

For further information please contact:

Investors

Media

Dmitry Yakushkin

MD Medical Group Investments Plc

 

Tel.: +7 (495) 139 87 40 ext. 16329

d.yakushkin@mcclinics.ru

EMTom Blackwell: +7 919 102 9064

Sergii Pershyn: +1 929 855 8188

MDMG@em-comms.com

About MD Medical Group

 

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

 

Forward-Looking Statements:

 

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMLJMBTMTBMTTM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.